A Simple and Rapid Method for Preparing a Cell-Free Bacterial Lysate for Protein Synthesis

PLoS One. 2016 Oct 21;11(10):e0165137. doi: 10.1371/journal.pone.0165137. eCollection 2016.

Abstract

Cell-free protein synthesis (CFPS) systems are important laboratory tools that are used for various synthetic biology applications. Here, we present a simple and inexpensive laboratory-scale method for preparing a CFPS system from E. coli. The procedure uses basic lab equipment, a minimal set of reagents, and requires less than one hour to process the bacterial cell mass into a functional S30-T7 extract. BL21(DE3) and MRE600 E. coli strains were used to prepare the S30-T7 extract. The CFPS system was used to produce a set of fluorescent and therapeutic proteins of different molecular weights (up to 66 kDa). This system was able to produce 40-150 μg-protein/ml, with variations depending on the plasmid type, expressed protein and E. coli strain. Interestingly, the BL21-based CFPS exhibited stability and increased activity at 40 and 45°C. To the best of our knowledge, this is the most rapid and affordable lab-scale protocol for preparing a cell-free protein synthesis system, with high thermal stability and efficacy in producing therapeutic proteins.

MeSH terms

  • Cell-Free System
  • Escherichia coli / metabolism*
  • Escherichia coli Proteins / biosynthesis*

Substances

  • Escherichia coli Proteins

Grants and funding

This work was supported by the EU-FP7 Marie Curie Program (No. 333797) - Dr. Avi Schroeder, Israel Science Foundation (No. 1778/13), Israel Cancer Association (No. 20150116), Israel Ministry of Economy (No. 52752), Israel Ministry of Science, Technology and Space (3-11878), GIF (No. 1-2328-1139. 10/20), ERC (2015-STG-680242), Mallat Family Foundation, The Russell Berrie Nanotechnology Institute (RBNI) at the Technion - Dr. Avi Schroeder, The Lorry Lokey Interdisciplinary Center for Life Sciences & Engineering at the Technion - Dr. Avi Schroeder, the Alon Fellowship from the Council For Higher Education and Taub Foundation Fellowships to A.S, and the "Baroness Ariane de Rothschild Women Doctoral Program" from the Rothschild Caesarea Foundation, and The Interdisciplinary Program for Biotechnology at the Technion (Mrs. Nitzan Krinsky). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.